{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T19:16:46Z","timestamp":1784747806303,"version":"3.55.0"},"reference-count":13,"publisher":"Universa BV","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AGEB"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:p>Microscopic colitis is a chronic inflammatory condition of the colon. Firstline treatment consists of budesonide, with the consideration of biological agents in refractory cases. Celiac disease is a chronic immune mediated and gluten-induced enteropathy, with treatment consisting of a gluten-free diet. There is an association between microscopic colitis and instead of xand celiac disease, especially in refractory cases they can coincide. In this manuscript, we report for the first time the efficacy of tofacitinib, a pan Janus kinase inhibitor, in the treatment of concomitant microscopic colitis and celiac disease, resulting in persistent clinical and histological remission.<\/jats:p>","DOI":"10.51821\/86.2.11639","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T20:54:28Z","timestamp":1689713668000},"page":"374-376","source":"Crossref","is-referenced-by-count":4,"title":["Tofacitinib for celiac disease and microscopic colitis: killing two birds with one stone"],"prefix":"10.51821","volume":"86","author":[{"given":"M","family":"Lenfant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"De Hertogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Verstockt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27062","published-online":{"date-parts":[[2023,6]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"MIEHLKE S, GUAGNOZZI D, ZABANA Y, TONTINI G, KANSTRUB FIEHN AM, WILDT S, et al. European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations. United European Gastroenterol J, 2021, 9(1):13-37.","DOI":"10.1177\/2050640620951905"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"LEBWOHL B, RUBIO-TAPIA A. Epidemiology, Presentation, and Diagnosis of Celiac Disease. Gastroenterology, 2021, 160(1):63-75.","DOI":"10.1053\/j.gastro.2020.06.098"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"AZIZ M, HAGHBIN H, KHAN RS, KHAN Z, WEISSMAN S, KAMAL F, et al. Celiac Disease Is Associated with Microscopic Colitis in Refractory Cases in Adults: A Systematic Review and Meta-Analysis of Observational Studies. Dig Dis Sci, 2022, 67(8):3529-3542.","DOI":"10.1007\/s10620-021-07232-7"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"SANDBORN W, SU C, SANDS B, D\u2019HAENS G, VERMEIRE S, SCHREIBER S, et al. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis. N Engl J Med, 2017, 377(5):496-497.","DOI":"10.1056\/nejmc1707500"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"WAUTERS L, VANUYTSEL T, HIELE M. Celiac Disease Remission With Tofacitinib: A Case Report. Ann Intern Med, 2020, 173(7):585.","DOI":"10.7326\/l20-0497"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"OBERHUBER G. Histopathology of Celiac Disease. Biomed Pharmcother, 2000, 54:368-372.","DOI":"10.1016\/S0753-3322(01)80003-2"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"BURKE K, D\u2019AMATO M, NG S, PARDI D, LUDVIGSSON J, KHALILI H. Microscopic Colitis. Nat Rev Dis Primers, 2021, 7(1):39.","DOI":"10.1038\/s41572-021-00273-2"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"BERGMAN D, CLEMENTS M, KHALIULI H, AGREUS L, HULTCRANTZ R, LUDVIGSSON J. A nationwide cohort study of the incidence of micro-scopic colitis in Sweden. Aliment Pharmacol Ther, 2019, 49(11):1395-1400.","DOI":"10.1111\/apt.15246"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"LEBWOHL B, RUBIO-TAPIA A. Epidemiology, Presentation and Diagnosis of Celiac Disease. Gastroenterology, 2021, 160(1):63-75.","DOI":"10.1053\/j.gastro.2020.06.098"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"JAMILLOUX Y, EL JAMMAL T, VUITTON L, GERFAUD-VALENTIN M, KEREVER S, SEVE P. JAK inhibitors for the treatment of autoimmune and  inflammatory diseases. Autoimun Rev, 2019, 18(11):102390.","DOI":"10.1016\/j.autrev.2019.102390"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"MIEHLKE S, VERHAEGH B, TONTINI G, MADISCH A, LANGNER C, MUNCH A. Microscopic colitis: pathophysiology and clinical management. Lancet Gastroenterol Hepatol, 2019, 4(4):305-314.","DOI":"10.1016\/s2468-1253(19)30048-2"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"PARZANESE I, QEHAJAJ D, PATRINIUCOLA F, ARALICA M, CHIRIVA-INTERNATI M, STIFTER S, et al. Celiac disease: From pathophysiology to treatment. World J Gastrointest Pathophysiol, 2017, 8(2):27-38.","DOI":"10.4291\/wjgp.v8.i2.27"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"MIYATANI Y, CHOI D, DU X, HART J, RUBIN T. Medically Refractory Lymphocytic Colitis Succesfully Treated With Upadacitinib. ACG Case Rep J, 2023, 10(2):e00979.","DOI":"10.14309\/crj.0000000000000979"}],"container-title":["Acta Gastro Enterologica Belgica"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T20:55:08Z","timestamp":1689713708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ageb.be\/ageb-journal\/ageb-volume\/ageb-article\/2107\/Tofacitinib%20for%20celiac%20disease%20and%20microscopic%20colitis:%20killing%20two%20birds%20with%20one%20stone\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":13,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,6]]},"published-print":{"date-parts":[[2023,6]]}},"URL":"https:\/\/doi.org\/10.51821\/86.2.11639","relation":{},"ISSN":["1784-3227"],"issn-type":[{"value":"1784-3227","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]}}}